B7-H3, also known as CD276, has been implicated in tumor growth, metastasis, and treatment resistance, all of which contribute to a bad prognosis for patients by assisting cancer cells in evading the surveillance by cytotoxic T cells and NK cells [189]. This evidence concerns the gene CD276 and cancer.